B-cell depletion for 2 years after autologous stem cell transplant for NHL induces prolonged hypogammaglobulinemia beyond the rituximab maintenance period.
Lim
Seah H
SH
Esler
William V
WV
Zhang
Yana
Y
Zhang
Jian
J
Periman
Phillip O
PO
Burris
Colleen
C
Townsend
Mary
M
D000328:Adult; D000361:Agammaglobulinemia / Q000209:etiology*; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007132:Immunoglobulin Isotypes / Q000097:blood; D008212:Lymphocyte Depletion / Q000009:adverse effects* / Q000379:methods; D008228:Lymphoma, Non-Hodgkin / Q000150:complications* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D013997:Time Factors; D019172:Transplantation Conditioning / Q000379:methods; D014182:Transplantation, Autologous
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007132:Immunoglobulin Isotypes; D000069283:Rituximab